Davies Collison Cave | Australia | 5 May 2020
The Federal Court of Australia has rejected the Australian Government’s claim for $325 million in damages from Sanofi. The claim was made under a…
Davies Collison Cave | Australia | 5 Dec 2013
The Australian Federal Court has recently made orders preventing generic pharmaceutical company, Generic Health, from promoting and selling generic…
Davies Collison Cave | Australia | 14 Nov 2012
The Federal Court has recently made orders restraining Hospira from promoting, supplying and obtaining PBS listing of products containing zoledronic acid until its final determination of Novartis’ allegations of patent infringement and Hospira’s cross-claims for invalidity.
Davies Collison Cave | Australia | 11 Sep 2012
Justice Jagot of the Federal Court has granted an interlocutory injunction prohibiting the promotion and sale of Apotex's generic versions of Merck's anti-allergic nasal spray, Nasonex.
Davies Collison Cave | Australia | 27 Aug 2012
The Full Court of the Federal Court of Australia has recently confirmed that Apotex did not have an implied licence to copy the Product Information (PI) for trade rival Sanofi's anti-arthritis drug, Arava (active ingredient leflunomide) for the purposes of obtaining TGA approval of Apotex's generic leflunomide products.
Davies Collison Cave | Australia | 28 Sep 2011
In a decision which considers both patent and copyright issues, the Federal Court recently found in favour of the patentee/originator, distinguishing between the purpose of administration and the result achieved in order to clarify construction of a method of treatment claim.
Davies Collison Cave | Australia | 28 Sep 2011
On 10 June 2011, Federal Court determined that B.M.W. Plastics Pty Ltd (“BMW Plastics”) infringed the principal claim of VIP Plastic Packaging Pty Ltd’s (“VIP”) Patent for a “variable dip length tube for a fluid transfer container”.
Davies Collison Cave | Australia | 31 May 2011
Further to our legal update in March, the Therapeutic Goods Legislation Amendment (Copyright) Bill 2011 has been passed by both Houses of Parliament, and has received royal assent.